Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53